Affiliation:
1. Harcourt Butler Technological Institute
Abstract
Antiplatelet drugs block the formation of blood clots by preventing the clumping of platelets inside arteries, particularly in individuals who have atherosclerosis of their arteries, or are otherwise prone to develop blood clots in their arteries. Atherosclerosis is a slow disease in which arteries become clogged and hardened. Fat, cholesterol, calcium, and other substances form plaque, which builds up in arteries. Hard plaque narrows the passage that blood flows through. That causes arteries to become hard and inflexible. Soft plaque is more likely to break free from the artery wall and cause a blood clot, which can block blood flow to vital organs. In this paper an attempt has been made to investigate the effects of antiplatelet drugs on blood flow and significance of non-Newtonian viscosity through a stenosed artery using Herschel-Bulkely fluid model. Numerical illustration presented at the end of the paper provides the results for the resistance to flow, apparent viscosity and the wall shear stress through their graphical representations.
Publisher
Trans Tech Publications, Ltd.
Subject
Biomedical Engineering,Bioengineering,Biotechnology
Reference23 articles.
1. Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy. Nature Rev 2003; 2: 15-28.
2. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-195.
3. Cambria-Kiely JA. Possible mechanisms of aspirin resistance. J Thromb Thrombolysis 2002; 13: 49-56.
4. Cokelet, G. R., The rheology of human blood. In Biomechanics, Ed. By Y. C. Fung et al., 63, Englewood Cliffs: Prentice-Hall, (1972).
5. Das, B., P.C. Johnson & A.S. Popel. Effect of non-axisymmetric hematocrit distribution on non-Newtonian blood flow in small tubes. Biorheology, Vol. 35, No. 1, pp.69-87, (1998).